M2 macrophage polarization (Tumor-associated macrophage polarization) (M2/TAM polarization)

M2 macrophage polarization refers to the alternative activation state of macrophages, characterized by anti-inflammatory properties and tissue-remodeling capabilities. In the tumor microenvironment, these cells are frequently termed tumor-associated macrophages (TAMs) and are recruited by factors such as CSF1 and CCL2 to support tumor progression. Once polarized to the M2 state, they facilitate angiogenesis via VEGF secretion, remodel the extracellular matrix, and suppress cytotoxic T-cell activity through the production of IL-10 and TGF-beta (Mantovani et al., 2017, Nature Reviews Clinical Oncology). This immunosuppressive environment is a major driver of resistance to standard therapies and checkpoint inhibitors. Therapeutic strategies targeting this state aim to either deplete these cells, block their recruitment, or "reprogram" them from an M2-like immunosuppressive phenotype to a pro-inflammatory M1-like phenotype (Kaneda et al., 2016, Nature). Beyond oncology, M2 polarization plays significant roles in chronic inflammatory diseases and tissue fibrosis, making it a complex but vital therapeutic focal point.

Other names

Alternative macrophage activationTumor-associated macrophage (TAM) polarizationM2-like activationPro-tumorigenic macrophage stateImmunosuppressive macrophage phenotype

Therapeutic modulation involves the depletion of M2-like macrophages (e.g., via CSF1R inhibition), inhibition of monocyte recruitment to the tumor microenvironment (e.g., via CCL2/CCR2 blockade), or phenotypic reprogramming from an immunosuppressive M2-like state to a pro-inflammatory, anti-tumor M1-like state (e.g., via PI3K-gamma inhibition) (Vitale et al., 2019, Nature Reviews Clinical Oncology).